Category: Chemotherapy
- Review of Pemetrexed in Combination with Cisplatin for the Treatment of Malignant Pleural Mesothelioma
Source: Therapeutics and Clinical Risk Management The current standard of care for the treatment of mesothelioma is combination chemotherapy using pemetrexed (Alimta) and cisplatin. The US FDA first approved this therapy in 2004, soon after the results of a large-scale, Phase III clinical trial were published that showed statistically significant improvements in median survival and …
Label: Chemotherapy Mesothelioma Treatments
Posted on Monday, Sep 15, 2008 - Erlotinib plus bevacizumab in previously treated patients with malignant pleural mesothelioma
Source: Cancer Even as improvements in the therapies available for mesothelioma patients have been made in recent years, the disease remains without cure. Most patients are ineligible for curative surgeries, so investigations into improving the efficacy of chemotherapy are among the most common research programs in contemporary mesothelioma treatment studies. Combination chemotherapy using pemetrexed and …
Label: Chemotherapy Mesothelioma Pleural Mesothelioma Treatments
Posted on Friday, Jul 25, 2008
